Viewing Study NCT02538393


Ignite Creation Date: 2025-12-25 @ 1:23 AM
Ignite Modification Date: 2026-02-25 @ 8:18 PM
Study NCT ID: NCT02538393
Status: COMPLETED
Last Update Posted: 2017-06-01
First Post: 2015-08-31
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Relative Bioavailability of Sorafenib Tablet for Oral Suspension
Sponsor: Bayer
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module